GSK vs PSIX · P/E 13, $103.31B cap vs P/E 8.8, rev $281.1M
GlaxoSmithKline PLC ADR (GSK) versus Power Solutions International, Inc. Common Stock (PSIX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Power Solutions International, Inc. Common Stock (PSIX) is a specialty industrial machinery company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported PSIX revenue for 2026-06-30 was $281.1M. Net income was $24.2M. PSIX currently screens at market cap $897.1M and trailing P/E 8.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. PSIX currently screens at market cap $897.1M and trailing P/E 8.8.
Not investment advice. Open the GSK and PSIX stock pages for the full models.
Not investment advice.